Re: Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer

Eur Urol. 2026 Apr 8:S0302-2838(26)02047-6. doi: 10.1016/j.eururo.2026.03.012. Online ahead of print.

¹ Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
² Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China. Electronic address: mahongzhi@hnca.org.cn.

No abstract available